Public spending on orphan medicines: a review of the literature

被引：0
|
作者：
Margit Gombocz
Sabine Vogler
机构：
[1] Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute),WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department
来源：
Journal of Pharmaceutical Policy and Practice | / 13卷
关键词：
Orphan medicines; Pharmaceutical expenditure; Public budgets; Review; Rare diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Public spending on orphan medicines: a review of the literature
    Gombocz, Margit
    Vogler, Sabine
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [2] Regulatory issues for orphan medicines: A review
    Bouwman, Maria Luisa
    Simoes Sousa, Joao Jose
    Tavares Pina, Maria Eugenia
    HEALTH POLICY AND TECHNOLOGY, 2020, 9 (01) : 115 - 121
  • [3] Rare diseases and orphan medicines: knowledge and perceptions of healthcare professionals and the public
    Vassallo, Sharon
    Pizzuto, Maresca Attard
    Azzopardi, Lilian M.
    Serracino-Inglott, Anthony
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 393 - 395
  • [4] Therapeutic profile of orphan medicines
    Teixeira de Barros, Carla Maria
    Papoila, Ana Luisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (04) : 435 - 440
  • [5] The pharmacist, rare diseases and orphan medicines
    Nagore, C.
    Lacalle, E.
    Arteche, L.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2008, 31 : 127 - 143
  • [6] Analysis of the evolution in the access to orphan medicines in Spain
    Mestre-Ferrandiz, Jorge
    Iniesta, Margarita
    Trapero-Bertran, Marta
    Espin, Jaime
    Brosa, Max
    GACETA SANITARIA, 2020, 34 (02) : 141 - 149
  • [7] Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
    Zelei, Tamas
    Molnar, Maria J.
    Szegedi, Marta
    Kalo, Zoltan
    ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
  • [8] Orphan medicines: a success with a challenging future
    Saint-Raymond, Agnes
    Llinares, Jordi
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (03): : 185 - 187
  • [9] REIMBURSED ORPHAN MEDICINES IN BULGARIA AND THE SHARE OF BIOTECHNOLOGY-DERIVED PRODUCTS
    Stoimenova, Assena
    Manova, Manoela
    Savova, Alexandra
    Angelovska, Bistra
    Petrova, Guenka
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2011, 25 (02) : 2418 - 2423
  • [10] Policies and availability of orphan medicines in outpatient care in 24 European countries
    Sarnola, Kati
    Ahonen, Riitta
    Martikainen, Jaana E.
    Timonen, Johanna
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (07) : 895 - 902
12345